Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient

   
   

Fused pyridazine derivatives represented by formula (I) or pharmaceutically acceptable salts thereof (wherein each symbol has the meaning as defined in the specification.). 1 Because of inhibiting poly(ADP-ribose)polymerase, the compounds represented by formula (I) are useful as preventives and/or remedies for various ischemic diseases (in brain, cord, heart, digestive tract, skeletal muscle, retina, etc.), inflammatory diseases (inflammatory bowel disease, multiple cerebrosclerosis, arthritis, etc.), neurodegenerative diseases (extrapyramidal disorder, Alzheimer's disease, muscular dystrophy, lumbar spinal canal stenosis, etc.), diabetes, shock, head trauma, renal failure, hyperalgesia, etc. Moreover, these compounds are useful as agents against retroviruses (HIV etc.), sensitizers in treating cancer and immunosuppressants.

Gesmolten pyridazine derivaten die door formule (I) of farmaceutisch aanvaardbare zouten worden vertegenwoordigd daarvan (waarin elk symbool de betekenis zoals die in de specificatie wordt bepaald heeft). 1 Wegens het verbieden poly(ADP-ribose)polymerase, de samenstellingen die door formule (I) worden vertegenwoordigd zijn nuttig als preventieve maatregelen en/of remedies voor diverse ischemische ziekten (in hersenen, koord, hart, spijsverteringskanaal, skeletachtige spier, retina, enz.), ontstekingsziekten (ontstekingsdarmziekte, veelvoudige cerebrosclerosis, artritis, enz.), neurodegenerative ziekten (extrapyramidal wanorde, de ziekte van Alzheimer, spierdystrofie, lumbale ruggegraatskanaalvernauwing, enz.), diabetes, schok, hoofdtrauma, niermislukking, hyperalgesia enz. Voorts zijn deze samenstellingen nuttig als agenten tegen retroviruses (HIV enz.), sensibilisators in het behandelen van kanker en immunosuppressants.

 
Web www.patentalert.com

< Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a methylxanthine derivative for treatment of asthma or chronic obstructive pulmonary disease

< Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease

> Oral formulation of lipid soluble thiamine, lipoic acid, creatine derivative, and L-arginine alpha-ketoglutarate

> Thiol-based NAALADase inhibitors

~ 00175